BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32246977)

  • 1. Extracellular vesicles for tumor targeting delivery based on five features principle.
    Yong T; Wang D; Li X; Yan Y; Hu J; Gan L; Yang X
    J Control Release; 2020 Jun; 322():555-565. PubMed ID: 32246977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
    Bai YT; Zhang XQ; Chen XJ; Zhou G
    Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for improved tumor accumulation and penetration.
    Bie N; Yong T; Wei Z; Gan L; Yang X
    Adv Drug Deliv Rev; 2022 Sep; 188():114450. PubMed ID: 35841955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles in cancer nanomedicine.
    Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
    Kotmakçı M; Bozok Çetintaş V
    J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer therapy based on extracellular vesicles as drug delivery vehicles.
    Cabeza L; Perazzoli G; Peña M; Cepero A; Luque C; Melguizo C; Prados J
    J Control Release; 2020 Nov; 327():296-315. PubMed ID: 32814093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as drug delivery systems: lessons from the liposome field.
    van der Meel R; Fens MH; Vader P; van Solinge WW; Eniola-Adefeso O; Schiffelers RM
    J Control Release; 2014 Dec; 195():72-85. PubMed ID: 25094032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of imaging in targeted delivery of nanomedicine for cancer therapy.
    Li P; Wang D; Hu J; Yang X
    Adv Drug Deliv Rev; 2022 Oct; 189():114447. PubMed ID: 35863515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
    Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
    ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles.
    Liu J; Ma J; Tang K; Huang B
    Methods Mol Biol; 2017; 1660():433-440. PubMed ID: 28828677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.